Compare metabolites in 2 of these studies:
Study A:   Study B:  

List of Studies ( Metabolite:TG 18:1/18:2/20:1)

Study_idAnalysis_idStudy_titleSourceSpeciesDiseaseInstituteAnalysis Type
ST004110 AN006813 Lipidomics characterization from plasma VLDL fractions isolated from human PNPLA3 wild type and human PNPLA3(I148M) knock in mice. Blood Mouse Liver disease Amgen LC-MS
ST003467 AN005699 Lipidomics of mice serum to support understanding of early metabolic shift in presymptomatic sepsis patients. (Part12 mice serum lipid) Blood Mouse Sepsis Leibniz Institute for Natural Product Research and Infection Biology Hans Knöll Institute LC-MS
ST002956 AN004853 An application of automated LLE extraction in determine the age and HFD effects in adult mice in metabolomic, lipidomic, and proteomic Blood Mouse Calico Life Sciences LC-MS
ST002545 AN004192 Lipidomic profile of Toxoplasma gondii-infected mice (Positive mode MS) Blood Mouse Cachexia University of Virginia LC-MS
ST002195 AN003594 Untargeted lipidomics studies in the course of dermatitis onset and progression Skin Mouse Dermatitis Keio University LC-MS
ST002079 AN003391 Defining the mammalian coactivation of hepatic 12-hour clock and lipid metabolism Liver Mouse Baylor College of Medicine Other
ST001313 AN002186 Lipid expression in serum after early life exposure to an endocrine disruptor and a Western Diet at 240 days postnatal (part-IV) Blood Rat Environmental exposure Baylor College of Medicine LC-MS
ST001312 AN002184 Lipid expression in serum after early lifer exposure to an endocrine disruptor at 70 days postnatal (part-III) Blood Rat Environmental exposure Baylor College of Medicine LC-MS
ST001311 AN002182 Lipid expression in liver after early lifer exposure to an endocrine disruptor at 70 days postnatal in the liver (part-II) Liver Rat Environmental exposure Baylor College of Medicine LC-MS
  logo